Clinical Trial: Role of Metabolomics in the Diagnosis of Endometriosis

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

Official Title: Role of Metabolomics in the Diagnosis of Endometriosis

Brief Summary:

Endometriosis is one of the most common benign gynecological, affecting about 10% of premenopausal women. The pathophysiology of this disease is still not completely clear. Despite its prevalence, there is no blood test available for the diagnosis of endometriosis and the average delay time to diagnosis is 9.4 years.

Metabolomics is a scientific discipline that studies changes in metabolites related to the pathophysiology of the disease.

Aim of the study is to identify an alteration in the expression of the metabolites in women with endometriosis

Detailed Summary:
Sponsor: University of Cagliari

Current Primary Outcome: Plasma and urine concentration of metabolites [ Time Frame: At least one month after discontinuation of hormonal therapies , before laparoscopic surgery ]

Original Primary Outcome: The study of metabolome of women affected by endometriosis [ Time Frame: At least one month after discontinuation of hormonal therapies , before laparoscopic surgery ]

Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Cagliari

Dates:
Date Received: January 9, 2015
Date Started: December 2014
Date Completion: August 2016
Last Updated: January 9, 2016
Last Verified: January 2016